Are Wall Street Analysts Predicting Boston Scientific Stock Will Climb or Sink?

With a market cap of $155.2 billion, Boston Scientific Corporation (BSX) develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. Based in Marlborough, Massachusetts, the company operates in two segments, MedSurg and Cardiovascular.

Shares of BSX have considerably surpassed the broader market over the past year. BSX has gained 45.7% over this time frame, while the broader S&P 500 Index ($SPX) has rallied 12.3%. In 2025, BSX gained 17.5%, compared to $SPX’s 3.3% decline.